Janssen launches global health unit

Share this article:

Johnson & Johnson's Janssen division has launched a global public health group. Janssen said in its Thursday announcement that the new division will unify Janssen's “commitment to research, develop and deliver transformational medicines to address the world's greatest unmet public health needs.”

Paul Stoffels, who is chief scientific officer of J&J and worldwide chairman of Janssen, said in a statement that the new unit gives the company "a more focused approach to further develop and introduce our most promising medicines."

The unit is also charged with increasing medication access and will build on and incorporate practices from Janssen's global access and partnerships program, which is focused on increasing access to HIV medications.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.